PT  - JOURNAL ARTICLE
AU  - Taccardi, Doriana
AU  - Gowdy, Hailey GM
AU  - Singer, Lesley
AU  - Daly-Cyr, Jennifer
AU  - Zacharias, Amanda M
AU  - Lu, Zihang
AU  - Choinière, Manon
AU  - Pagé, M Gabrielle
AU  - Ghasemlou, Nader
TI  - The CircaHealth CircaPain study protocol: A longitudinal multi-site study of the chronobiological control of chronic pain
AID  - 10.1101/2024.03.22.24304751
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.22.24304751
4099  - http://medrxiv.org/content/early/2024/03/24/2024.03.22.24304751.short
4100  - http://medrxiv.org/content/early/2024/03/24/2024.03.22.24304751.full
AB  - Introduction One in five Canadians lives with chronic pain. Evidence shows that some individuals experience pain that fluctuates in intensity following a circadian (24-hour) rhythm. Endogenous molecular rhythms regulate the function of most physiological processes, neuroimmunology functions that govern pain mechanisms. Addressing chronic pain rhythmicity on a molecular and biopsychosocial level can advance understanding of the disease and identify new treatment/management strategies. Our CircaHealth CircaPain study uses an online survey combined with ecological momentary assessments and bio-sample collection to investigate the circadian control of chronic pain and identify potential biomarkers. Our primary objective is to understand inter-individual variability in pain rhythmicity, by collecting biopsychosocial measures. The secondary objective accounts for seasonal variability and the effect of latitude on rhythmicity.Methods and analysis Following completion of a baseline questionnaire, participants complete a series of electronic symptom-tracking diaries to rate their pain intensity, negative affect, and fatigue on a 0-10 scale at 8:00, 14:00, and 20:00 daily over 10 days. These measures are repeated at 6- and 12-months post-enrolment to account for potential seasonal changes. Infrastructure is being developed to facilitate the collection of blood samples from subgroups of participants 2 times per day over 24-48 hours to identify rhythmic expression of circulating genes and/or proteins.Ethics and dissemination Ethical approval for this study was obtained by the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board. Findings will be published in a relevant scientific journal and disseminated at national and international scientific meetings and online webinars. We maintain a website to post updated resources and engage with the community. We employ knowledge mobilization in the form of direct data sharing with participants. This study is funded by the Canadian Institutes of Health Research (CIHR) (grant PJT-497592) and the CIHR Strategy for Patient-Oriented Research (SPOR) Chronic Pain Network (CPN) (grant SCA-145102).Ethical approval date: 08 March 2024Estimated start of the study: April 2024Strengths and limitations of this studyData will be collected using self-report questionnaires only, which may lead to random or systematic misreporting.The online nature of the study might affect the diversity in our sample (e.g., the representation of rural and/or underprivileged communities).Physical distance from research laboratories with specialized equipment for analyses and biobanking storage might affect accessibility, however, this can be overcome by using mailable dried blood spot collection kits as described.Questionnaires used in our study have previously been validated in the chronic pain population and used in several languages.Uncovering distinct pain rhythmicity patterns and health outcomes associated with rhythmicity may help develop new treatments for different chronic pain conditions tailored to individual circadian rhythms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is funded by a Canadian Institutes of Health Research (CIHR) project grant (PJT-497592) to NG and MGP, and a sub-grant from the CIHR Strategy for Patient Oriented Research (SPOR) Chronic Pain Network (SCA-145102) to NG. MGP is a Junior 2 research scholar from the Fonds de recherche du Quebec en sante.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Queens University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board Board (DBMS-160-23) File No 6038114I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesN/a protocol paper